What is the level of liabilities of Somalogic this year?
Somalogic has a debt balance of 84.8 M USD this year.
Somalogic Liabilities 2025
Somalogic Liabilities
84.8 M USD
Ticker
SLGC
ISIN
US83444K1051
WKN
A3C14K
In 2025, Somalogic's total liabilities amounted to 84.8 M USD, a 0% difference from the 0 USD total liabilities in the previous year.
Somalogic Aktienanalyse
What does Somalogic do?
SomaLogic Inc is a diagnostic biotech company specializing in a new way of clinically diagnosing diseases. It was founded in 2000 by Larry Gold, a renowned researcher and pioneer in the field of molecular diagnostics. The idea behind Somalogic arose from the need to bridge the gap between clinical needs and conventional diagnostic methods. SomaLogic's business model can be described as a service provider and licensee. The company offers its customers a wide range of products and services, from technology development to clinical disease diagnosis. The model is based on Somalogic's unique ability to measure a large number of proteins simultaneously, thus creating a comprehensive picture of their biological activity. The spheres of Somalogic encompass three main areas: proteins, data, and biomedicine. The protein sphere refers to Somalogic's core competence in the field of proteomics. The company has developed a proprietary technology that allows for the measurement of up to 5000 proteins in a single sample. Somalogic's technology is based on a special sample format called "SOMAScan," which utilizes proprietary aptamer technology to achieve ultra-high protein molecular signature accuracy. Somalogic's data sphere is deeply rooted in both the protein sphere and the biomedicine sphere. The company has a proprietary database that encompasses thousands of proteins. This database is continuously updated and expanded to provide increasingly robust quantitative protein data. The database enables Somalogic to identify and validate specific protein signatures associated with diseases. Somalogic also utilizes machine learning and artificial intelligence tools to take the interpretation of this data to the next level. The biomedicine sphere of Somalogic is the area where the company brings its diagnostic and therapeutic developments to the market. Somalogic works closely with pharmaceutical companies and clinical laboratories to develop clinical diagnostic tests based on its proprietary technology. The company has generated valid clinical data on a range of diseases and demonstrated the ability to identify biomarkers specifically associated with certain diseases. In its business development, Somalogic has created and licensed a wide range of products. The company has successfully formed partnerships with a number of companies and institutions to provide both proteomics tools and services. Some notable examples include partnerships such as collaboration with Biogen in the development of diagnostic tools for multiple sclerosis and other neurological disorders. Another example of Somalogic's product range is the successful collaboration with the New York State Health Department, where the company used its technology to investigate the SARS-CoV-2 virus. In this context, Somalogic generated information about specific biomarkers for COVID-19 and other masked and bound viral diseases. SomaLogic has the potential to change the way diseases are diagnosed and therapeutically treated. The company is on a path to revolutionize the diagnostic capabilities of the healthcare system and leave its mark on the healthcare market. Somalogic ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Somalogic's Liabilities
Somalogic's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Somalogic's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Somalogic's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Somalogic's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Somalogic’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Somalogic stock
What were the liabilities of Somalogic compared to the previous year?
The liabilities of Somalogic have increased by 0% dropped compared to the previous year.
What are the consequences of high debt for investors of Somalogic?
High liabilities can pose a risk for investors of Somalogic, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Somalogic?
Low liabilities mean that Somalogic has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Somalogic affect the company?
An increase in liabilities of Somalogic can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Somalogic affect the company?
A decrease in the liabilities of Somalogic can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Somalogic?
Some factors that can influence the liabilities of Somalogic include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Somalogic so important for investors?
The liabilities of Somalogic are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Somalogic take to modify the liabilities?
To change its liabilities, Somalogic can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Somalogic pay?
Over the past 12 months, Somalogic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Somalogic is expected to pay a dividend of 0 USD.
What is the dividend yield of Somalogic?
The current dividend yield of Somalogic is .
When does Somalogic pay dividends?
Somalogic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Somalogic?
Somalogic paid dividends every year for the past 0 years.
What is the dividend of Somalogic?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Somalogic located?
Somalogic is assigned to the 'Health' sector.
Wann musste ich die Aktien von Somalogic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Somalogic from 1/13/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/13/2025.
When did Somalogic pay the last dividend?
The last dividend was paid out on 1/13/2025.
What was the dividend of Somalogic in the year 2024?
In the year 2024, Somalogic distributed 0 USD as dividends.
In which currency does Somalogic pay out the dividend?
The dividends of Somalogic are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Somalogic
Our stock analysis for Somalogic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Somalogic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.